3 posts tagged with "European Patient Digital Health"

The ceremony attended by European technology executives aims to promote digital innovation.​

The European Patient Digital Health Awards (PDHA) ceremony, orchestrated by MSD — known for their innovation in COVID-19 treatment —, recently honored Legit.Health for its groundbreaking work in healthcare technology. Marking a significant milestone, Legit.Health is celebrated as the first Spanish company to clinch the PDHA award, a testament to its commitment to transforming patient care through digital innovation.

The Transformative Impact of Our AI-Driven Dermatological Technology on Society and Healthcare​

Since she was little, Andy Aguilar knew that many things were wrong with her skin. And when she needed doctors, she was met with an ordeal.

She was held back by primary care, and then passed around from specialist to specialist, collecting incorrect diagnosis after incorrect diagnosis and taking the brunt of the consequences of the misguided treatments that came with them as her frustration with her healthcare providers grew. Each new appointment came with its ever-extending waiting period, as her symptoms worsened before her eyes.

That's why she founded Legit.Health, based on her experience as a patient, and with first-hand knowledge of how to fix the system and rescue patients.

This collaboration will integrate Legit.Health's innovative technology into Aptar Digital Health's proprietary digital health platform to better manage and treat skin conditions

Aptar Digital Health, a global expert in Software as a Medical Device (SaMD), digital Patient Support Programs (PSPs) and disease management solutions, today announced a new partnership with Legit.Health, an innovative artificial intelligence (AI)-based medical device (CE-marked) software company, which aims to transform patient care and increase patient adherence to better manage skin conditions.

Legit.Health's state-of-the-art technology, which supports the diagnosis of approximately 300 conditions, including atopic dermatitis, psoriasis and skin cancer, will be integrated into Aptar's Digital Health proprietary platform. Focused on enhancing patient care and increasing patient autonomy, this advanced digital solution will support healthcare professionals (HCPs) to diagnose skin conditions earlier and will enable patients to start sooner on treatment plans to improve their overall quality of life. The solution may also be used to facilitate patient enrolment in clinical trials.